Retraction

The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease

Paper Information

Record ID:
64366
Publication Date:
November 21, 2012
Retraction Date:
March 12, 2025 (<1 year years ago)
Subjects:
Article Type:
Publisher:
Society for Neuroscience
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

see also: https://pubpeer.com/publications/841806329CBD4CD2593E83C5E369EA

Citations (273)

273
Total Citations
2
Post-Retraction
(0.7%)
271
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
63 Days since retraction (latest)
The role of membranes in function and dysfunction of intrinsically disordered amyloidogenic proteins
Bani Kumar Pathak, Sandip Dey, Sukanya Mozumder et al. (4 authors)
Advances in protein chemistry and structural biology
Published: Jan 2022
2 citations
1166 days before retraction
Prions and Neurodegenerative Diseases: A Focus on Alzheimer’s Disease
Alessio Crestini, Francesca Santilli, Stefano Martellucci et al. (7 authors)
Journal of Alzheimer s Disease Open Access
Published: Nov 2021
25 citations
1198 days before retraction
PrPC as a Transducer of Physiological and Pathological Signals
Jessica Panes, Paulina Saavedra, Benjamin Pineda et al. (10 authors)
Frontiers in Molecular Neuroscience Open Access
Published: Nov 2021
14 citations
1206 days before retraction
Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease
Pranesh Padmanabhan, Andrew Kneynsberg, Jürgen Götz
Nature reviews. Neuroscience
Published: Nov 2021
47 citations
1227 days before retraction
Anti‐PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease
Ruolin Li, Ming Ren, Yingxin Yu
Brain and Behavior Open Access
Published: Oct 2021
4 citations
1238 days before retraction
Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease
Khaled S. Abd‐Elrahman, Stephen S. G. Ferguson
The Annual Review of Pharmacology and Toxicology
Published: Sep 2021
55 citations
1276 days before retraction
Prion protein and prion disease at a glance
Caihong Zhu, Adriano Aguzzi
Journal of Cell Science Open Access
Published: Sep 2021
16 citations
1288 days before retraction
Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Rajmohamed Mohamed Asik, Natarajan Suganthy, Mohamed Asik Aarifa et al. (9 authors)
Biomedicines Open Access
Published: Sep 2021
39 citations
1288 days before retraction
Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?
Bianca Guglietti, Srisankavi Sivasankar, Sanam Mustafa et al. (5 authors)
Molecular Neurobiology
Published: Aug 2021
35 citations
1295 days before retraction
GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
Stefania Demuro, Rita Maria Concetta Di Martino, José Antonio Ortega et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Aug 2021
64 citations
1297 days before retraction
Estradiol exerts a neuroprotective effect on SH‐SY5Y cells through the miR‐106b‐5p/TXNIP axis
Qiong Pan, Ke Guo, Min Xue et al. (4 authors)
Journal of Biochemical and Molecular Toxicology
Published: Jul 2021
12 citations
1323 days before retraction
Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers
Ladan Amin, David A. Harris
Nature Communications Open Access
Published: Jun 2021
40 citations
1373 days before retraction
Interactions of Amyloid-β with Membrane Proteins
Benita Wiatrak, Janusz Piasny, Amadeusz Kuźniarski et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Jun 2021
32 citations
1377 days before retraction
The <scp>IDIP</scp> framework for assessing protein function and its application to the prion protein
Gerold Schmitt‐Ulms, Mohadeseh Mehrabian, Declan Williams et al. (4 authors)
Biological reviews/Biological reviews of the Cambridge Philosophical Society Open Access
Published: May 2021
9 citations
1406 days before retraction
Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future Approaches
Laura Trujillo‐Estrada, Elisabeth Sánchez‐Mejías, Raquel Sánchez‐Varo et al. (11 authors)
The Neuroscientist
Published: Mar 2021
21 citations
1447 days before retraction
Tetramethylpyrazine Improves Cognitive Impairment and Modifies the Hippocampal Proteome in Two Mouse Models of Alzheimer's Disease
Xian‐Feng Huang, Jinyao Yang, Xi Huang et al. (7 authors)
Frontiers in Cell and Developmental Biology Open Access
Published: Mar 2021
30 citations
1458 days before retraction
Neurodegenerative Disease and the NLRP3 Inflammasome
Jonathan Holbrook, Heledd Jarosz-Griffiths, Emily A. Caseley et al. (8 authors)
Frontiers in Pharmacology Open Access
Published: Mar 2021
153 citations
1463 days before retraction
Alzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networks
Niall Murphy
Unknown Journal
Published: Mar 2021
1464 days before retraction
Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains
Reisuke H. Takahashi, Mayumi Yokotsuka, Minoru Tobiume et al. (7 authors)
Brain Pathology Open Access
Published: Feb 2021
24 citations
1478 days before retraction
Transcriptomic analysis of zebrafish prion protein mutants supports conserved cross-species function of the cellular prion protein
Niall M. Pollock, Patricia L.A. Leighton, Gavin J. Neil et al. (4 authors)
Prion Open Access
Published: Jan 2021
4 citations
1531 days before retraction
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
Huiqin Zhang, Wei Wei, Ming Zhao et al. (8 authors)
International Journal of Biological Sciences Open Access
Published: Jan 2021
336 citations
1531 days before retraction
Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo–PrP<sup>C</sup>binding and downstream pathways
James D. Grayson, Matthew P. Baumgartner, Cleide Dos Santos Souza et al. (23 authors)
Chemical Science Open Access
Published: Jan 2021
8 citations
1531 days before retraction
Alzheimer’s Disease and Protein Kinases
Ayşe Başak Engin, Atilla Engin
Advances in experimental medicine and biology
Published: Jan 2021
30 citations
1531 days before retraction
ATAC-seq and psychiatric disorders
John F. Fullard, Jaroslav Bendl, Panos Roussos
Elsevier eBooks
Published: Jan 2021
1531 days before retraction
Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases
Amalia Merelli, Marisa G. Repetto, Alberto Lazarowski et al. (4 authors)
Journal of Alzheimer s Disease
Published: Dec 2020
132 citations
1554 days before retraction
Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies
Tao Yang, Kevin Tran, Anne Y. Zeng et al. (5 authors)
Scientific Reports Open Access
Published: Nov 2020
31 citations
1570 days before retraction
Isoform‐specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer's disease and Lewy body dementias
Clara Ying Bei Low, Jasinda H. Lee, Frances Ting Wei Lim et al. (8 authors)
Brain Pathology Open Access
Published: Oct 2020
35 citations
1593 days before retraction
Soluble Prion Peptide 107–120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer’s Disease
Elham Rezvani Boroujeni, Seyed Masoud Hosseini, Giulia Fani et al. (5 authors)
International Journal of Molecular Sciences Open Access
Published: Oct 2020
5 citations
1623 days before retraction
Caffeoyl-Prolyl-Histidine Amide Inhibits Fyn and Alleviates Atopic Dermatitis-Like Phenotypes via Suppression of NF-κB Activation
Hayan Jeong, Jee Youn Shin, Kwanghyun Lee et al. (13 authors)
International Journal of Molecular Sciences Open Access
Published: Sep 2020
11 citations
1626 days before retraction
Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction
Hajar Miranzadeh Mahabadi, Changiz Taghibiglou
International Journal of Molecular Sciences Open Access
Published: Sep 2020
38 citations
1629 days before retraction
Frontotemporal dementia mutant tau (P301L) locks Fyn in an open, active conformation conducive to nanoclustering
Christopher Small, Ramón Martínez‐Mármol, Tristan P. Wallis et al. (6 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Sep 2020
4 citations
1648 days before retraction
Role of tau protein in Alzheimer's disease: The prime pathological player
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran et al. (5 authors)
International Journal of Biological Macromolecules
Published: Aug 2020
192 citations
1676 days before retraction
Fyn Kinase Controls Tau Aggregation In Vivo
Adam Briner, Jürgen Götz, Juan Carlos Polanco
Cell Reports Open Access
Published: Aug 2020
72 citations
1684 days before retraction
Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy
Si Jie Tang, Arman Fesharaki‐Zadeh, Hideyuki Takahashi et al. (9 authors)
Acta Neuropathologica Communications Open Access
Published: Jul 2020
59 citations
1715 days before retraction
Fyn Tyrosine Kinase as Harmonizing Factor in Neuronal Functions and Dysfunctions
Carmela Matrone, Federica Petrillo, Rosarita Nasso et al. (4 authors)
International Journal of Molecular Sciences Open Access
Published: Jun 2020
76 citations
1724 days before retraction
LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer’s Disease Cell Culture Models
Katelyn Cuttler, Monique J. Bignoux, Tyrone C. Otgaar et al. (6 authors)
Journal of Alzheimer s Disease
Published: Jun 2020
5 citations
1727 days before retraction
The biogenesis and biology of amyloid β oligomers in the brain
Karen H. Ashe
Alzheimer s & Dementia Open Access
Published: Jun 2020
36 citations
1730 days before retraction
Soluble endogenous oligomeric α-synuclein species in neurodegenerative diseases: Expression, spreading, and cross-talk
Rakez Kayed, Ulf Dettmer, Sylvain Lesné
Journal of Parkinson s Disease Open Access
Published: Jun 2020
49 citations
1744 days before retraction
Cancer and Alzheimer’s disease inverse relationship: an age-associated diverging derailment of shared pathways
Cristina Lanni, Mirco Masi, Marco Racchi et al. (4 authors)
Molecular Psychiatry
Published: May 2020
99 citations
1770 days before retraction
Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation
Behnam Mohammadi, Luise Linsenmeier, Mohsin Shafiq et al. (13 authors)
Molecular Neurobiology Open Access
Published: May 2020
22 citations
1773 days before retraction
The cellular prion protein beyond prion diseases
Giorgia Manni, Victoria Lewis, Matteo Senesi et al. (8 authors)
Schweizerische medizinische Wochenschrift Open Access
Published: Apr 2020
20 citations
1783 days before retraction
The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain
Rosalina Gavı́n, Laia Lidón, Isidró Ferrer et al. (4 authors)
Cells Open Access
Published: Mar 2020
23 citations
1836 days before retraction
Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer’s Disease Mice
Xiaoguang Yao, Xiao‐Hui Xian, Mingxing Fang et al. (5 authors)
Frontiers in Aging Neuroscience Open Access
Published: Jan 2020
21 citations
1867 days before retraction
PET imaging of mGluR5 in Alzheimer’s disease
Adam P. Mecca, Julia W. McDonald, Hannah R. Michalak et al. (15 authors)
Alzheimer s Research & Therapy Open Access
Published: Jan 2020
46 citations
1880 days before retraction
Related Network and Differential Expression Analyses Identify Nuclear Genes and Pathways in the Hippocampus of Alzheimer Disease
Xuemei Quan, Liang Huo, Ya Chen et al. (6 authors)
Medical Science Monitor Open Access
Published: Jan 2020
30 citations
1881 days before retraction
LRP::FLAG reduces phosphorylated tau levels in Alzheimer’s Disease
Katelyn Cuttler, Monique J. Bignoux, Tyrone C. Otgaar et al. (6 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Jan 2020
1 citation
1883 days before retraction
Targeting dementias through cancer kinases inhibition
Francesca Fagiani, Cristina Lanni, Marco Racchi et al. (4 authors)
Alzheimer s & Dementia Translational Research & Clinical Interventions Open Access
Published: Jan 2020
41 citations
1897 days before retraction
Effects of anle138b treatment on amyloid-β neurotoxicity
Carolina Thomas
Unknown Journal Open Access
Published: Jan 2020
1897 days before retraction
On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases
Giuseppe Legname, Carlo Scialò
Prion Open Access
Published: Jan 2020
23 citations
1897 days before retraction
The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates
Carlo Scialò, Giuseppe Legname
Progress in molecular biology and translational science
Published: Jan 2020
9 citations
1897 days before retraction
Quick Stats
Total Citations: 273
Years Since Retraction: <1 year
Open Access: Yes
Last Checked: Jul 23, 2025